Phase II, proof-of-concept study of buccal spray insulin on postprandial hyperglycaemia in patients with impaired glucose tolerance

Trial Profile

Phase II, proof-of-concept study of buccal spray insulin on postprandial hyperglycaemia in patients with impaired glucose tolerance

Completed
Phase of Trial: Phase II

Latest Information Update: 07 Dec 2011

At a glance

  • Drugs Insulin (Primary)
  • Indications Glucose intolerance; Hyperglycaemia; Type 2 diabetes mellitus
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms PREVORAL
  • Most Recent Events

    • 07 Dec 2011 Results will be presented at the International Diabetes Federation (IDF) Congress.
    • 14 Mar 2011 Status changed from active, no longer recruiting to completed.
    • 13 Dec 2010 Results will be published in Diabetes, Obesity and Metabolism [Volume 13, Issue 1 (January 2011)], according to a Generex Biotechnology Corporation media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top